{"status":"ok","message-type":"work","message-version":"1.0.0","message":{"indexed":{"date-parts":[[2026,9,18]],"date-time":"2026-09-18T04:52:37Z","timestamp":1789707157817,"version":"4.0.1"},"reference-count":43,"publisher":"Oxford University Press (OUP)","issue":"6","license":[{"start":{"date-parts":[[2018,9,10]],"date-time":"2018-09-10T00:00:00Z","timestamp":1536537600000},"content-version":"vor","delay-in-days":0,"URL":"https:\/\/academic.oup.com\/journals\/pages\/open_access\/funder_policies\/chorus\/standard_publication_model"}],"funder":[{"DOI":"10.13039\/100000026","name":"National Institute on Drug Abuse","doi-asserted-by":"publisher","award":["DA034083"],"award-info":[{"award-number":["DA034083"]}],"id":[{"id":"10.13039\/100000026","id-type":"DOI","asserted-by":"publisher"}]},{"DOI":"10.13039\/100000026","name":"National Institute on Drug Abuse","doi-asserted-by":"publisher","id":[{"id":"10.13039\/100000026","id-type":"DOI","asserted-by":"publisher"}]}],"content-domain":{"domain":[],"crossmark-restriction":false},"short-container-title":[],"published-print":{"date-parts":[[2019,6,1]]},"DOI":"10.1093\/pm\/pny179","type":"journal-article","created":{"date-parts":[[2018,8,9]],"date-time":"2018-08-09T20:28:59Z","timestamp":1533846539000},"page":"1148-1155","source":"Crossref","is-referenced-by-count":33,"title":["Correlates of Benzodiazepine Use and Adverse Outcomes Among Patients with Chronic Pain Prescribed Long-term Opioid Therapy"],"prefix":"10.1093","volume":"20","author":[{"given":"Bobbi Jo H","family":"Yarborough","sequence":"first","affiliation":[{"name":"Kaiser Permanente Northwest Center for Health Research, Portland, Oregon"}],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Scott P","family":"Stumbo","sequence":"additional","affiliation":[{"name":"Kaiser Permanente Northwest Center for Health Research, Portland, Oregon"}],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Ashley","family":"Stoneburner","sequence":"additional","affiliation":[{"name":"Kaiser Permanente Northwest Center for Health Research, Portland, Oregon"}],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Ning","family":"Smith","sequence":"additional","affiliation":[{"name":"Kaiser Permanente Northwest Center for Health Research, Portland, Oregon"}],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Steven K","family":"Dobscha","sequence":"additional","affiliation":[{"name":"Center to Improve Veteran Involvement in Care, VA Portland Health Care System, Portland, Oregon"},{"name":"Department of Psychiatry, Oregon Health & Science University, Portland, Oregon"}],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Richard A","family":"Deyo","sequence":"additional","affiliation":[{"name":"Kaiser Permanente Northwest Center for Health Research, Portland, Oregon"},{"name":"Departments of Family Medicine, Internal Medicine, and the Oregon Institute for Occupational Health Sciences, Oregon Health & Science University, Portland, Oregon, USA"}],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Benjamin J","family":"Morasco","sequence":"additional","affiliation":[{"name":"Center to Improve Veteran Involvement in Care, VA Portland Health Care System, Portland, Oregon"},{"name":"Department of Psychiatry, Oregon Health & Science University, Portland, Oregon"}],"role":[{"vocabulary":"crossref","role":"author"}]}],"member":"286","published-online":{"date-parts":[[2018,9,10]]},"reference":[{"issue":"2","key":"2019053120005209300_pny179-B1","doi-asserted-by":"crossref","first-page":"136","DOI":"10.1001\/jamapsychiatry.2014.1763","article-title":"Benzodiazepine use in the United States","volume":"72","author":"Olfson","year":"2015","journal-title":"JAMA Psychiatry"},{"issue":"9","key":"2019053120005209300_pny179-B2","doi-asserted-by":"crossref","first-page":"1","DOI":"10.15585\/mmwr.ss6409a1","article-title":"Controlled substance prescribing patterns\u2014prescription behavior surveillance system, eight states, 2013","volume":"64","author":"Paulozzi","year":"2015","journal-title":"MMWR Surveill Summ"},{"issue":"26","key":"2019053120005209300_pny179-B3","doi-asserted-by":"crossref","first-page":"697","DOI":"10.15585\/mmwr.mm6626a4","article-title":"Vital signs: Changes in opioid prescribing in the United States, 2006-2015","volume":"66","author":"Guy","year":"2017","journal-title":"MMWR Morb Mortal Wkly Rep"},{"issue":"4","key":"2019053120005209300_pny179-B4","doi-asserted-by":"crossref","first-page":"493","DOI":"10.1007\/s40268-017-0207-7","article-title":"Benzodiazepines and Z-drugs: An updated review of major adverse outcomes reported on in epidemiologic research","volume":"17","author":"Brandt","year":"2017","journal-title":"Drugs R D"},{"issue":"4","key":"2019053120005209300_pny179-B5","doi-asserted-by":"crossref","first-page":"281","DOI":"10.1177\/1060028016682530","article-title":"Benzodiazepine initiation and dose escalation: A risk factor for inpatient falls","volume":"51","author":"Skinner","year":"2017","journal-title":"Ann Pharmacother"},{"key":"2019053120005209300_pny179-B6","first-page":"1","article-title":"Drug-poisoning deaths involving opioid analgesics: United States, 1999-2011","volume":"166","author":"Chen","year":"2014","journal-title":"NCHS Data Brief"},{"issue":"29","key":"2019053120005209300_pny179-B7","first-page":"377","article-title":"Poisoning deaths involving opioid analgesics\u2014New York State, 2003-2012","volume":"64","author":"Sharp","year":"2015","journal-title":"MMWR Morb Mortal Wkly Rep"},{"key":"2019053120005209300_pny179-B8","doi-asserted-by":"crossref","first-page":"1081","DOI":"10.1007\/s11606-015-3199-4","article-title":"Drug overdose in a retrospective cohort with non-cancer pain treated with opioids, antidepressants, and\/or sedative-hypnotics: Interactions with mental health disorders","volume":"30","author":"Turner","year":"2015","journal-title":"J Gen Intern Med"},{"key":"2019053120005209300_pny179-B9","doi-asserted-by":"crossref","first-page":"h2698.","DOI":"10.1136\/bmj.h2698","article-title":"Benzodiazepine prescribing patterns and deaths from drug overdose among US veterans receiving opioid analgesics: Case-cohort study","volume":"350","author":"Park","year":"2015","journal-title":"BMJ"},{"key":"2019053120005209300_pny179-B10","doi-asserted-by":"crossref","first-page":"j760","DOI":"10.1136\/bmj.j760","article-title":"Association between concurrent use of prescription opioids and benzodiazepines and overdose: Retrospective analysis","volume":"356","author":"Sun","year":"2017","journal-title":"BMJ"},{"issue":"2","key":"2019053120005209300_pny179-B11","doi-asserted-by":"crossref","first-page":"356","DOI":"10.1111\/pme.12594","article-title":"Benzodiazepine use among chronic pain patients prescribed opioids: Associations with pain, physical and mental health, and health service utilization","volume":"16","author":"Nielsen","year":"2015","journal-title":"Pain Med"},{"key":"2019053120005209300_pny179-B12","author":"Day","year":"2013"},{"issue":"5","key":"2019053120005209300_pny179-B13","doi-asserted-by":"crossref","first-page":"492","DOI":"10.1007\/s11606-015-3571-4","article-title":"The association between receipt of guideline-concordant long-term opioid therapy and all-cause mortality","volume":"31","author":"Gaither","year":"2016","journal-title":"J Gen Intern Med"},{"issue":"1\u20132","key":"2019053120005209300_pny179-B14","doi-asserted-by":"crossref","first-page":"8","DOI":"10.1016\/j.drugalcdep.2012.07.004","article-title":"Polydrug abuse: A review of opioid and benzodiazepine combination use","volume":"125","author":"Jones","year":"2012","journal-title":"Drug Alcohol Depend"},{"issue":"1","key":"2019053120005209300_pny179-B15","doi-asserted-by":"crossref","first-page":"59","DOI":"10.1124\/jpet.117.240200","article-title":". Preference for an opioid\/benzodiazepine mixture over an opioid alone using a concurrent choice procedure in rhesus monkeys","volume":"362","author":"Weed","year":"2017","journal-title":"J Pharmacol Exp Ther"},{"issue":"1","key":"2019053120005209300_pny179-B16","doi-asserted-by":"crossref","first-page":"1","DOI":"10.15585\/mmwr.rr6501e1","article-title":"CDC guideline for prescribing opioids for chronic pain\u2014United States, 2016","volume":"65","author":"Dowell","year":"2016","journal-title":"MMWR Recomm Rep"},{"key":"2019053120005209300_pny179-B17","volume-title":"Clinical Practice Guideline for Opioid Therapy for Chronic Pain","author":"Department of Veterans Affairs, Department of Defense","year":"2017"},{"issue":"26","key":"2019053120005209300_pny179-B18","first-page":"563","article-title":"Vital signs: Variation among states in prescribing of opioid pain relievers and benzodiazepines\u2014United States, 2012","volume":"63","author":"Paulozzi","year":"2014","journal-title":"MMWR Morb Mortal Wkly Rep"},{"issue":"4","key":"2019053120005209300_pny179-B19","doi-asserted-by":"crossref","first-page":"516","DOI":"10.1080\/08897077.2016.1179242","article-title":"The association between benzodiazepine prescription and aberrant drug-related behaviors in primary care patients receiving opioids for chronic pain","volume":"37","author":"Park","year":"2016","journal-title":"Subst Abus"},{"issue":"1","key":"2019053120005209300_pny179-B20","first-page":"85","article-title":"Cohort study of the impact of high-dose opioid analgesics on overdose mortality","volume":"17","author":"Dasgupta","year":"2016","journal-title":"Pain Med"},{"issue":"19","key":"2019053120005209300_pny179-B21","doi-asserted-by":"crossref","first-page":"2087","DOI":"10.1001\/archinte.166.19.2087","article-title":"Association between mental health disorders, problem drug use, and regular prescription opioid use","volume":"166","author":"Sullivan","year":"2006","journal-title":"Arch Intern Med"},{"key":"2019053120005209300_pny179-B22","doi-asserted-by":"crossref","first-page":"58","DOI":"10.1016\/j.drugalcdep.2017.01.013","article-title":"Benzodiazepine, z-drug and pregabalin prescriptions and mortality among patients in opioid maintenance treatment\u2014a nation-wide register-based open cohort study","volume":"174","author":"Abrahamsson","year":"2017","journal-title":"Drug Alcohol Depend"},{"issue":"1","key":"2019053120005209300_pny179-B23","doi-asserted-by":"crossref","first-page":"14","DOI":"10.1080\/10550887.2016.1211784","article-title":"Opioid analgesic and benzodiazepine prescribing among Medicaid-enrollees with opioid use disorders: The influence of provider communities","volume":"36","author":"Stein","year":"2017","journal-title":"J Addict Dis"},{"issue":"3","key":"2019053120005209300_pny179-B24","doi-asserted-by":"crossref","first-page":"451","DOI":"10.1097\/j.pain.0000000000001111","article-title":"Relationship between concomitant benzodiazepine-opioid use and adverse outcomes among US veterans","volume":"159","author":"Gressler","year":"2018","journal-title":"Pain"},{"issue":"3","key":"2019053120005209300_pny179-B25","doi-asserted-by":"crossref","first-page":"355","DOI":"10.1016\/j.pain.2007.02.014","article-title":"Risk factors for clinically recognized opioid abuse and dependence among veterans using opioids for chronic non-cancer pain","volume":"129","author":"Edlund","year":"2007","journal-title":"Pain"},{"issue":"6","key":"2019053120005209300_pny179-B26","doi-asserted-by":"crossref","first-page":"521","DOI":"10.1097\/AJP.0b013e318169d03b","article-title":"De facto long-term opioid therapy for noncancer pain","volume":"24","author":"Von Korff","year":"2008","journal-title":"Clin J Pain"},{"issue":"4","key":"2019053120005209300_pny179-B27","doi-asserted-by":"crossref","first-page":"437","DOI":"10.1016\/j.jpain.2016.12.004","article-title":"Higher prescription opioid dose is associated with worse patient-reported pain outcomes and more health care utilization","volume":"18","author":"Morasco","year":"2017","journal-title":"J Pain"},{"issue":"3","key":"2019053120005209300_pny179-B28","doi-asserted-by":"crossref","first-page":"281","DOI":"10.1097\/00004479-200407000-00011","article-title":"Comorbidity assessments based on patient report: Results from the Veterans Health Study","volume":"27","author":"Selim","year":"2004","journal-title":"J Ambul Care Manage"},{"issue":"1","key":"2019053120005209300_pny179-B29","doi-asserted-by":"crossref","first-page":"140","DOI":"10.1097\/j.pain.0000000000000730","article-title":"Incident and long-term opioid therapy among patients with psychiatric conditions and medications: A national study of commercial health care claims","volume":"158","author":"Quinn","year":"2017","journal-title":"Pain"},{"key":"2019053120005209300_pny179-B30","article-title":"Sedative prescriptions are common at opioid initiation: An observational study in the Veterans Health Administration","author":"Mosher","year":"2017","journal-title":"Pain Med"},{"key":"2019053120005209300_pny179-B31","doi-asserted-by":"crossref","first-page":"249","DOI":"10.2147\/JPR.S122853","article-title":"Co-prescription of opioids with benzodiazepine and other co-medications among opioid users: Differential in opioid doses","volume":"10","author":"Zin","year":"2017","journal-title":"J Pain Res"},{"issue":"5","key":"2019053120005209300_pny179-B32","doi-asserted-by":"crossref","first-page":"354","DOI":"10.1097\/ADM.0b013e31829e3957","article-title":"Comparative safety of benzodiazepines and opioids among Veterans Affairs patients with posttraumatic stress disorder","volume":"7","author":"Hawkins","year":"2013","journal-title":"J Addict Med"},{"issue":"5","key":"2019053120005209300_pny179-B33","doi-asserted-by":"crossref","first-page":"283","DOI":"10.5055\/jom.2017.0397","article-title":"Trends in Florida\u2019s prescription drug monitoring program registration and utilization: Implications for increasing voluntary use","volume":"13","author":"Delcher","year":"2017","journal-title":"J Opioid Manag"},{"issue":"9","key":"2019053120005209300_pny179-B34","doi-asserted-by":"crossref","first-page":"1896","DOI":"10.1016\/j.clinthera.2017.07.040","article-title":"The role of continuing medical education in increasing enrollment in prescription drug monitoring programs","volume":"39","author":"Finnell","year":"2017","journal-title":"Clin Ther"},{"issue":"7","key":"2019053120005209300_pny179-B35","doi-asserted-by":"crossref","first-page":"747","DOI":"10.1016\/j.jpain.2014.04.003","article-title":"Who uses a prescription drug monitoring program and how? Insights from a statewide survey of Oregon clinicians","volume":"15","author":"Irvine","year":"2014","journal-title":"J Pain"},{"issue":"2","key":"2019053120005209300_pny179-B36","doi-asserted-by":"crossref","first-page":"166","DOI":"10.1007\/s11606-017-4211-y","article-title":"Managing concerning behaviors in patients prescribed opioids for chronic pain: A Delphi study","volume":"33","author":"Merlin","year":"2018","journal-title":"J Gen Intern Med"},{"issue":"10","key":"2019053120005209300_pny179-B37","doi-asserted-by":"crossref","first-page":"1838","DOI":"10.1093\/pm\/pnw078","article-title":"Patients\u2019 perspectives on tapering of chronic opioid therapy: A qualitative study","volume":"17","author":"Frank","year":"2016","journal-title":"Pain Med"},{"issue":"3","key":"2019053120005209300_pny179-B38","doi-asserted-by":"crossref","first-page":"308","DOI":"10.1016\/j.jpain.2016.11.003","article-title":"Prescription opioid taper support for outpatients with chronic pain: A randomized controlled trial","volume":"18","author":"Sullivan","year":"2017","journal-title":"J Pain"},{"issue":"3","key":"2019053120005209300_pny179-B39","doi-asserted-by":"crossref","first-page":"181","DOI":"10.7326\/M17-0598","article-title":"Patient outcomes in dose reduction or discontinuation of long-term opioid therapy: A systematic review","volume":"167","author":"Frank","year":"2017","journal-title":"Ann Intern Med"},{"key":"2019053120005209300_pny179-B40","first-page":"CD009652","article-title":"Psychosocial interventions for benzodiazepine harmful use, abuse or dependence","volume":"5","author":"Darker","year":"2015","journal-title":"Cochrane Database Syst Rev"},{"issue":"3","key":"2019053120005209300_pny179-B41","first-page":"454","article-title":"Survey of primary care and mental health prescribers\u2019 perspectives on reducing opioid and benzodiazepine co-prescribing among veterans","volume":"18","author":"Hawkins","year":"2017","journal-title":"Pain Med"},{"key":"2019053120005209300_pny179-B42","article-title":"\u201cThose conversations in my experience don\u2019t go well\u201d: A qualitative study of primary care provider experiences tapering long-term opioid medications","author":"Kennedy","year":"2017","journal-title":"Pain Med"},{"issue":"2","key":"2019053120005209300_pny179-B43","doi-asserted-by":"crossref","first-page":"157","DOI":"10.1080\/08897077.2017.1290011","article-title":"Implementation of a pharmacy consult to reduce co-prescribing of opioids and benzodiazepines in a Veteran population","volume":"38","author":"Pardo","year":"2017","journal-title":"Subst Abus"}],"container-title":["Pain Medicine"],"original-title":[],"language":"en","link":[{"URL":"http:\/\/academic.oup.com\/painmedicine\/article-pdf\/20\/6\/1148\/28752276\/pny179.pdf","content-type":"unspecified","content-version":"vor","intended-application":"similarity-checking"}],"deposited":{"date-parts":[[2020,11,7]],"date-time":"2020-11-07T14:30:24Z","timestamp":1604759424000},"score":1,"resource":{"primary":{"URL":"https:\/\/academic.oup.com\/painmedicine\/article\/20\/6\/1148\/5094680"}},"subtitle":[],"short-title":[],"issued":{"date-parts":[[2018,9,10]]},"references-count":43,"journal-issue":{"issue":"6","published-online":{"date-parts":[[2018,9,10]]},"published-print":{"date-parts":[[2019,6,1]]}},"URL":"https:\/\/doi.org\/10.1093\/pm\/pny179","relation":{},"ISSN":["1526-2375","1526-4637"],"issn-type":[{"value":"1526-2375","type":"print"},{"value":"1526-4637","type":"electronic"}],"subject":[],"published-other":{"date-parts":[[2019,6]]},"published":{"date-parts":[[2018,9,10]]}}}